FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

CENTESSA PHARMACEUTICALS PLC: cashflow_investing

One fact, its scope and the complete path back to the official record.

Period: 2023-01-01 – 2023-09-30Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/3c1a621c-ed78-4eb9-88af-0b7fb4fb4817

Reported value

$-108.729M{"amount": -108729000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Entity
CENTESSA PHARMACEUTICALS PLC
Metric
cashflow_investing
Period
2023-01-01 – 2023-09-30
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001847903-23-000189 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T18:36:35.281764+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001847903/cashflow-investing/2023-09-30 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.